SSRI Treatment suppresses dream recall frequency but increases subjective dream intensity in normal subjects

@article{PaceSchott2001SSRITS,
  title={SSRI Treatment suppresses dream recall frequency but increases subjective dream intensity in normal subjects},
  author={Edward F. Pace-Schott and Tamara Gersh and Rosalia Silvestri and Robert Stickgold and Carl Salzman and J. Allan Hobson},
  journal={Journal of Sleep Research},
  year={2001},
  volume={10}
}
Clinical lore and a small number of published studies report that the selective serotonin reuptake inhibitors (SSRIs) intensify dreaming. This study examines the dream effects of paroxetine and fluvoxamine in order to both increase clinical knowledge of these agents and to test an important potential method for probing the relationship between REM sleep neurobiology and dreaming in humans. Fourteen normal, paid volunteers (4 males, 10 females; mean age 27.4 year, range 22–39) free of medical or… Expand
Serotonin and dreaming
Many clinical anecdotes and an experimental study have reported intensification of dreaming by the selective serotonin-reuptake inhibitors (SSRIs). However, no published neurochemical dream modelExpand
Dreaming under antidepressants: a systematic review on evidence in depressive patients and healthy volunteers.
TLDR
The major finding, both in depressed patients and in healthy volunteers, is a decrease of dream recall frequency (DRF) under ADs, a rather consistent effect in tricyclic ADs and phenelzine, less consistently documented also for SSRIs/serotonin norepinephrine reuptake inhibitors (SNRIs). Expand
Changes in dream experience in relation with antidepressant escitalopram treatment in depressed female patients: a preliminary study.
TLDR
The results of the present study evidence how the changes in some specific dreaming characteristics, such as the subjective recall of dream activity, the dreaming recall quality, the dream emotional content and the dream complexity represent reliable markers of the effectiveness of antidepressant therapy. Expand
The effect of trimipramine on dream recall and dream emotions in depressive outpatients
TLDR
The present findings support the continuity hypothesis of dreaming by demonstrating a close link between waking-life symptomatolgy and negative dream emotions. Expand
Dreams, Sleep, and Psychotropic Drugs
TLDR
The reduction of intra-sleep awakenings seems to be the parameter explaining best the modulation of DRF by psychotropic drugs, which is coherent with the “arousal-retrieval model” stating that nighttime awakenings enable dreams to be encoded into long-term memory and therefore facilitate dream recall. Expand
Drug Effects on Dreaming
Among the proposed functions of dreaming in human being, the most research supports are mood-regulation, problem-solving, learning, and memory construction. Recent imaging techniques have providedExpand
Chapter 97 – Idiopathic Nightmares and Dream Disturbances Associated with Sleep–Wake Transitions
TLDR
Nightmares and other common disturbances of dreaming involve a perturbation of emotional expression during sleep and involve dysphoric emotions ranging from malaise to fear to frank terror. Expand
Sertraline and rapid eye movement sleep without atonia: An 8-week, open-label study of depressed patients
  • Bin Zhang, Y. Hao, +4 authors I. Arnulf
  • Medicine, Psychology
  • Progress in Neuro-Psychopharmacology and Biological Psychiatry
  • 2013
TLDR
In contrast to idiopathic RBD, sertraline-related RSWA had the specific characteristics of being correlated with the degree of the prolonging of REM latency and no predominance of male sex and elder age, suggesting different pathophysiological mechanisms. Expand
Dreaming without REM sleep
TLDR
It is suggested that the generation of mental activity during sleep is independent of sleep stage, and long, complex and bizarre dreams persist even after suppressing REM sleep either partially or totally. Expand
Nightmares and bad dreams in patients with borderline personality disorder: Fantasy as a coping skill?
ABSTRACT – Background and Objectives: Previous studies reported a high prevalence of nightmares and dream anxiety in Borderline Personality Disorder (BPD) and the severity of dream disturbancesExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 118 REFERENCES
Investigations of morning and laboratory dream recall and content in depressive patients during baseline conditions and under antidepressive treatment with trimipramine.
TLDR
Morning as well as laboratory dream recall in depressive inpatients was drastically reduced and antidepressive treatment with trimipramine led to a positive influence on patients' mood that was paralleled by a change of dream mood in a positive direction. Expand
Effects of fluvoxamine and paroxetine on sleep structure in normal subjects: a home-based Nightcap evaluation during drug administration and withdrawal.
TLDR
The laboratory polysomnographic findings of SSRI-induced sleep quality changes are confirmed and the Nightcap's efficacy as an inexpensive longitudinal monitor for objective sleep changes induced by psychotropic medication is demonstrated. Expand
Sleep laboratory studies on the single-dose effects of serotonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities.
TLDR
Sleep quality, attention, concentration and reaction performance improved under paroxetine as compared to baseline, and the deterioration of well-being under PX 40 might be related to the appearance of drowsiness and nausea. Expand
REM sleep enhancement by bupropion in depressed men.
TLDR
This study represents the first report of an antidepressant medication that shortens REM latency and increases REM sleep and may require a revision of the current understanding of the relation among depression, REM sleep, and anti-depressant mechanisms. Expand
Effects of Fluoxetine on the Polysomnogram in Outpatients with Major Depression
TLDR
After fluoxetine was discontinued, total REM sleep and sleep efficiency were found to be increased as compared to baseline, and subjective measures of sleep indicated a steady improvement during acute phase treatment. Expand
Medication and Dreams: Changes in Dream Content After Drug Treatment
This case study examines the effects of sertraline (ZoloftTM) on the dream content of a young woman with generalized anxiety disorder and panic attacks. The study used the major categories of HallExpand
Citalopram in the treatment of obsessive‐compulsive disorder: an open pilot study
TLDR
The results suggest that citalopram may be effective in the treatment of obsessive‐compulsive disorder. Expand
The cholinergic rapid eye movement sleep induction test with RS-86. State or trait marker of depression?
TLDR
The application of this compound before sleep led to a significantly faster induction of REM sleep at the beginning of the night in patients with major depressive disorders compared with healthy subjects and patients with other nondepressive psychiatric diseases, such as eating disorders. Expand
Serotonin reuptake inhibitor withdrawal.
TLDR
Reports of withdrawal symptoms in a retrospective chart review of 352 patients treated in an outpatient clinic with the nonselective serotonin reuptake inhibitor clomipramine or with one of the selective SSRIs, fluoxetine, fluvoxamine, paroxettine, or sertraline suggest a role has been suggested for serotonin in coordinating sensory and autonomic function with motor activity. Expand
Intrinsic dreams are not produced without REM sleep mechanisms: evidence through elicitation of sleep onset REM periods
TLDR
Although ‘dreaming’ may occur during both REM and NREM periods as previous researchers have suggested, the dreams obtained from these distinct periods differ significantly in their quantitative and qualitative aspects and are likely to be produced by different mechanisms. Expand
...
1
2
3
4
5
...